Ulrike Westhoff

652 total citations
19 papers, 517 citations indexed

About

Ulrike Westhoff is a scholar working on Immunology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ulrike Westhoff has authored 19 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Hematology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ulrike Westhoff's work include T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (6 papers). Ulrike Westhoff is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (6 papers). Ulrike Westhoff collaborates with scholars based in Germany, United States and Netherlands. Ulrike Westhoff's co-authors include H. Grosse‐Wilde, Rainer Blasczyk, Hans Grosse‐Wilde, Ilias I.N. Doxiadis, Hilde Götz, Friedrich P. Thinnes, Dietrich W. Beelen, UW Schaefer, Herbert Tilg and Walter E. Aulitzky and has published in prestigious journals such as The Lancet, Clinical & Experimental Immunology and Human Immunology.

In The Last Decade

Ulrike Westhoff

19 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Westhoff Germany 11 336 117 71 68 53 19 517
P Rebello United Kingdom 12 274 0.8× 133 1.1× 122 1.7× 118 1.7× 42 0.8× 19 550
D P King United States 9 320 1.0× 60 0.5× 103 1.5× 22 0.3× 44 0.8× 12 498
Ricardo A. Brooimans Netherlands 7 387 1.2× 134 1.1× 30 0.4× 52 0.8× 36 0.7× 7 530
AD Hess United States 11 261 0.8× 376 3.2× 30 0.4× 30 0.4× 35 0.7× 16 554
S Strober United States 17 520 1.5× 249 2.1× 137 1.9× 101 1.5× 29 0.5× 42 809
Roseanna Hargreaves United Kingdom 14 550 1.6× 232 2.0× 40 0.6× 107 1.6× 42 0.8× 22 856
Paul I. Terasaki United States 8 287 0.9× 62 0.5× 32 0.5× 203 3.0× 44 0.8× 10 651
Janne Ø. Bohnhorst Norway 6 386 1.1× 53 0.5× 55 0.8× 14 0.2× 49 0.9× 6 576
Rita Vasconcellos Brazil 10 393 1.2× 31 0.3× 31 0.4× 22 0.3× 79 1.5× 14 570
Jean-François Séïté France 6 268 0.8× 83 0.7× 128 1.8× 13 0.2× 24 0.5× 7 395

Countries citing papers authored by Ulrike Westhoff

Since Specialization
Citations

This map shows the geographic impact of Ulrike Westhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Westhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Westhoff more than expected).

Fields of papers citing papers by Ulrike Westhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Westhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Westhoff. The network helps show where Ulrike Westhoff may publish in the future.

Co-authorship network of co-authors of Ulrike Westhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Westhoff. A scholar is included among the top collaborators of Ulrike Westhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Westhoff. Ulrike Westhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schaller, Jörg, et al.. (2009). Lack of HLA-molecules on human spermatozoa and in seminal plasma. Andrologia. 25(2). 77–81. 6 indexed citations
2.
Goldmann, Torsten, et al.. (1999). Prognostic Classification of Malignant Melanomas by Combining Clinical, Histological, and Immunohistochemical Parameters. Oncology. 56(3). 208–214. 25 indexed citations
3.
Westhoff, Ulrike, Christopher P. Fox, & F. Otto. (1999). Quantification of cathepsin D in plasma of patients with malignant melanoma.. PubMed. 18(5B). 3785–8. 6 indexed citations
4.
Westhoff, Ulrike, et al.. (1999). Soluble HLA class I antigens in plasma of patients with malignant melanoma.. PubMed. 18(5B). 3789–92. 12 indexed citations
5.
Ott, Mélanie, et al.. (1998). Soluble HLA class I and class II antigens in patients with multiple sclerosis. Tissue Antigens. 51(3). 301–304. 34 indexed citations
6.
Westhoff, Ulrike & Hans Grosse‐Wilde. (1995). Soluble HLA Class I and Class II Concentrations in Factor VIII and PCC Preparations. Vox Sanguinis. 68(2). 73–76. 17 indexed citations
7.
Buelow, Roland, Isabelle Le Mercier, Frans H.J. Claas, et al.. (1995). Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Human Immunology. 44(1). 1–11. 58 indexed citations
8.
Kreuzfelder, E., K. Quabeck, Marius Braun, et al.. (1995). Association of increased bronchoalveolar lavage fluid albumin and serum beta 2-microglobulin with pulmonary complications after allogeneic bone marrow transplantation.. PubMed. 16(2). 249–52. 3 indexed citations
9.
Westhoff, Ulrike & Hans Grosse‐Wilde. (1995). Soluble HLA Class I and Class II Concentrations in Factor VIII and PCC Preparations. Vox Sanguinis. 68(2). 73–76. 3 indexed citations
10.
Moritz, Thomas, et al.. (1994). Soluble HLA Class I and Beta‐2‐Microglobulin Plasma Concentrations during Interferon Treatment of Chronic Myelogenous Leukemia. Vox Sanguinis. 67(3). 310–314. 9 indexed citations
11.
Blasczyk, Rainer, Ulrike Westhoff, & H. Grosse‐Wilde. (1993). Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. The Lancet. 341(8848). 789–790. 137 indexed citations
12.
Westhoff, Ulrike & H. Grosse‐Wilde. (1993). Quantitation of soluble HLA-DR, DQ, DP antigens using superantigens as detection molecules. Human Immunology. 37(2). 132–132. 1 indexed citations
13.
14.
Grosse‐Wilde, H., Rainer Blasczyk, & Ulrike Westhoff. (1992). Soluble HLA class I and class II concentrations in commercial immunoglobuh preparations. Tissue Antigens. 39(2). 74–77. 49 indexed citations
15.
Westhoff, Ulrike, Friedrich P. Thinnes, Hilde Götz, & Hans Grosse‐Wilde. (1991). Quantitation of Soluble HLA Class II Molecules by an Enzyme‐Linked Immunosorbent Assay. Vox Sanguinis. 61(2). 106–110. 31 indexed citations
16.
Aulitzky, Walter E., H. Grosse‐Wilde, Ulrike Westhoff, et al.. (1991). Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-γ). Clinical & Experimental Immunology. 86(2). 236–239. 43 indexed citations
17.
Westhoff, Ulrike, Friedrich P. Thinnes, Hilde Götz, & Hans Grosse‐Wilde. (1991). Quantitation of Soluble HLA Class II Molecules by an Enzyme-Linked Immunosorbent Assay. Vox Sanguinis. 61(2). 106–110. 2 indexed citations
18.
Doxiadis, Ilias I.N., Ulrike Westhoff, & Hans Grosse‐Wilde. (1989). Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Annals of Hematology. 59(5). 449–454. 49 indexed citations
19.
Westhoff, Ulrike, Ilias I.N. Doxiadis, Dietrich W. Beelen, UW Schaefer, & H. Grosse‐Wilde. (1989). Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation.. PubMed. 48(5). 891–3. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026